📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
30
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
37%
📉 Score Deterioration
40%
• Score rose 33 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($200M, 212% of market cap)
• Active ATM program with $100M remaining capacity
🔄 Reverse Split
30%
• 50-day avg $1.85 approaching $1 threshold
💹 Market Data
Market Cap$94.39M
Shares Outstanding49.68M
Float39.32M
Cash$74.80M
Debt$2.33M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 368.8% shares (2025Q4 vs prior)
49 institutional holders · 16.75M shares
#1
EcoR1 Capital, LLC
2.23M shares
#2
Affinity Asset Advisors, LLC
2.06M shares
#3
Logos Global Management LP
2.00M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.41M
Days to Cover3.6
% of Float8.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jun 30, 2024
xbrl
XBRL CONVERTIBLE
Jun 30, 2024
424B3
ATM
Apr 29, 2026
8-K/A
8K EVENT
Apr 17, 2026
8-K
8K EVENT
Apr 08, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for IBIO
📊 IBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 IBIO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.